Visit iDataResearch.com
  Cardiovascular & Infusion Therapy Newsletter
  April 2018
 
Feature Story:

European Interventional Cardiology Market Declines in 2018 as a Result of 3 Key Market Factors

The total European market for interventional cardiology devices was valued at approximately €1.2 billion in 2017, an apparent decrease over the previous year. The growth of the European markets for interventional cardiology devices, which historically were boosted by growing angioplasty and angiography procedure numbers, will continue to experience declines due to three major market factors. Similar to other medical device markets, the first factor impacting the interventional cardiology market is the ...

Read full press release online

Minimally Invasive Surgery for Mitral Valve Disease to be Tested in Trial

A new cardiac surgical procedure to treat mitral valve disease, which is minimally invasive, does not require open-heart surgery, and offers faster recovery, is being tested in an upcoming clinical trial. Mitral valve disease occurs when the heart’s mitral valve — which has two flaps that open and close to allow blood to flow — cannot close or open properly. There are two types of mitral valve disease: stenosis, when the valve does not open enough to allow sufficient blood flow; and regurgitation, when the blood leaks backward, preventing blood flow from the lungs to the rest of the body, making the heart work harder. Without timely treatment, mitral valve disease can lead to several complications, including...

read more}

 

XableCath Granted United States Patent for its Peripheral Arterial Catheters

XableCath, Inc., innovators of products designed to aid in the treatment of peripheral artery disease (PAD), announced that it has been granted a second U.S. Patent, No. 9,826,995, covering its XableCath™ catheter. The patent specifically describes a catheter that controls tissue contact and has a rigid ring implement that opens a blood vessel occlusion by rotating the ring against the occlusion, thus clearing the vessel and providing access across the lesion.“Our proprietary design enables the XableCath to easily slide past an occluding atheroma through the true lumen of the vessel,” stated XableCath President and Chief Executive Officer, Lisa Dunlea. “The granting of this second patent provides broad coverage and a strong foundation for XableCath’s intellectual property portfolio and...

read more}

 

Proteon Therapeutics Completes Enrollment in PATENCY-2, Phase 3 Clinical Trial of Investigational Vonapanitase

Proteon Therapeutics, Inc., a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today announced that it has completed enrollment in PATENCY-2, the second Phase 3 clinical trial of investigational vonapanitase, Proteon’s lead development candidate. Top-line data from this trial is expected in March of 2019. PATENCY-2 is a multicenter, randomized, double-blind, placebo-controlled Phase 3 clinical trial in patients with chronic kidney disease (CKD) receiving or expecting to receive hemodialysis and undergoing surgical creation of a radiocephalic arteriovenous fistula. The trial is designed to evaluate...

read more}

 
 
 
  Browse Report Categories  
 

Cardiac Rhythm Management

Cardiac Surgery

Electrophysiology and Ablation Devices

Interventional Cardiology

Infusion Therapy

Peripheral Vascular

Vascular Access

BROWSE ALL

 
 
 

Latest Publications

 
 

US Market Report Suite For Peripheral Vascular Devices 2018 - MedSuite

US Market Report Suite for Interventional Cardiology Devices 2018 – MedSuite

Europe Market Report Suite for Interventional Cardiology Devices 2018 – MedSuite

US Market Report Suite for Vascular Access Devices and Accessories 2018 – MedSuite

US Market Report Suite for Infusion Therapy Devices 2018 – MedSuite

US Market Report Suite For Cardiac Surgery And Heart Valve Devices 2018 - MedSuite

Mexico Market Report Suite For Minimally Invasive Spinal Implants 2018 - MedSuite

Brazil Market Report Suite For Minimally Invasive Spinal Implants 2018 - MedSuite

Argentina Market Report Suite For Minimally Invasive Spinal Implants 2018 - MedSuite

US Market Report Suite for Video and Integrated Operating Room Equipment 2018 – MedSuite

 
  View More  
   
 
 
 
 

Upcoming Publications

 
 

Europe Market Report Suite For Soft Tissue Reinforcement And Regeneration 2018 - MedSuite

Mexico Market Report Suite For Spinal Implants and VCF Devices 2018 - MedSuite

Argentina Market Report Suite For Spinal Implants and VCF Devices 2018 - MedSuite

Brazil Market Report Suite For Spinal Implants And Vertebral Compression Fracture Devices 2018 - MedSuite

 
  View More  
     
 
 
 
Search All iData Report Categories
 
  WEBSITE | ABOUT | Blog | CONTACT | STAY CONNECTED facebook twitter linkedin  
 
iData Research | 308 - 4211 Kingsway, Burnaby BC, V5H 1Z6 | Tel: 604-266-6933 | [email protected]

Click here to unsubscribe from the iData Monthly Newsletter